Role of external pallidal segment in primate parkinsonism: Comparison of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsionism and lesions of the external pallidal segment

Journal of Neuroscience

Volumn 24, Issue 29, 2004, Pages 6417-6426

  Soares, Jesus ^a   Kliem, Michele A ^a   Betarbet, Ranjita ^a   Greenamyre, J Timothy ^a   Yamamoto, Bryan ^b   Wichmann, Thomas ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Extracelular recording; Globus pallidus; Lesion; Microdialysis; Parkinson's disease; Subthalamic nucleus

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; GLUTAMATE DEHYDROGENASE;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; GLOBUS PALLIDUS; HISTOLOGY; MICRODIALYSIS; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RHESUS MONKEY; SUBTHALAMIC NUCLEUS;

ACTION POTENTIALS; ANIMALS; BASAL GANGLIA; BEHAVIOR, ANIMAL; GAMMA-AMINOBUTYRIC ACID; GLOBUS PALLIDUS; MACACA MULATTA; MICRODIALYSIS; MPTP POISONING; NEURONS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; SUBTHALAMIC NUCLEUS;

EID: 3242792377     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0836-04.2004     Document Type: Article

References (58)

1. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
2. Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266-271.
3. Alexander GE, Crutcher MD, DeLong MR (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 85:119-146.
4. Alvarez L, Macias R, Guridi J, Lopez G, Alvarez E, Maragoto C, Teijeiro J, Torres A, Pavon N, Rodriguez-Oroz MC, Ochoa L, Hetherington H, Juncos J, DeLong MR, Obeso JA (2001) Dorsal subthalamotomy for Parkinson's disease. Mov Disord 16:72-78.
5. Bacci JJ, Kerkerian-Le Goff L, Salin P (2002) Effects of intralaminar thalamic nuclei lesion on glutamic acid decarboxylase (GAD65 and GAD67) and cytochrome oxidase subunit I mRNA expression in the basal ganglia of the rat. Eur J Neurosci 15:1918-1928.
6. Bankiewicz KS, Oldfield EH, Chiuch CC, Doppman JL, Jacobowitz DM, Kopin IJ (1986) Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci 39:7-16.
7. Baron MS, Wichmann T, Ma D, DeLong MR (2002) Effects of transient focal inactivation of the basal ganglia in parkinsonian primates. J Neurosci 22:592-599.
8. Bergman H, Wichmann T, DeLong MR (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249:1436-1438.
9. Bergman H, Wichmann T, Karmon B, DeLong MR (1994) The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 72:507-520.
10. Besson MJ, Graybiel AM, Nastuk MA (1988) [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions. Neuroscience 26:101-119.
11. Bevan MD, Magill PJ, Terman D, Bolam JP, Wilson CJ (2002) Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci 25:525-531.
12. Campbell GA, Eckardt MJ, Weight FF (1985) Doparninergic mechanisms in subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresis. Brain Res 333:261-270.
13. Delfs JM, Ciaramitaro VM, Parry TJ, Chesselet MF (1995) Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats. J Neurosci 15:6562-6575.
14. DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285.
15. Donzanti BA, Yamamoto BK (1988) A rapid and simple HPLC microassay for biogenic amines in discrete brain regions. Pharmacol Biochem Behav 30:795-799.
16. Filion M (1979) Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey. Brain Res 178:425-441.
17. Filion M, Tremblay L (1991) Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 547:142-151.
18. Francois C, Savy C, Jan C, Tande D, Hirsch EC, Yelnik J (2000) Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys, and in Parkinson's disease patients. J Comp Neurol 425:121-129.
19. Gill SS, Heywood P (1997) Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease. Lancet 350:1224.
20. Guridi J, Luquin MR, Guillen J, Herrero MT, Obeso JA (1993) Antiparkinsonian effect of subthalamotomy in MPTP-monkeys of different severity. Mov Disord 9:1910.
21. Hamada I, DeLong MR (1992) Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. J Neurophysiol 68:1859-1866.
22. Hassani OK, Mouroux M, Feger J (1996) Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience 72:105-115.
23. Herrero MT, Ruberg M, Hirsch EC, Guridi J, Luquin MR, Guillen J, Javoy-Agid F, Agid Y, Obeso JA (1993) Changes in GAD mRNA expression in neurons of the internal pallidum in parkinsonian monkeys after L-DOPA therapy. Soc Neurosci Abstr 19:132.
24. Herrero MT, Levy R, Ruberg M, Javoy-Agid F, Luquin MR, Agid Y, Hirsch EC, Obeso JA (1996a) Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkeys and patients with Parkinson's disease. Adv Neurol 69:209-216.
25. Herrero MT, Levy R, Ruberg M, Luquin MR, Villares J, Guillen J, Faucheux B, Javoy-Agid F, Guridi J, Agid Y, Obeso JA, Hirsch EC (1996b) Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum. Neurology 47:219-224.
26. Johnson AE, Coirini H, Kallstrom L, Wiesel FA (1994) Characterization of dopamine receptor binding sites in the subthalamic nucleus. NeuroReport 5:1836-1838.
27. Kreiss DS, Mastropietro CW, Rawji SS, Walters JR (1997) The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J Neurosci 17:6807-6819.
28. Legendy CR, Salcman M (1985) Bursts and recurrences of bursts in the spike trains of spontaneously active striate cortex neurons. J Neurophysiol 53:926-939.
29. Magill PJ, Bolam JP, Bevan MD (2000a) Relationship of activity in the subthalamic nucleus-globus pallidus network to cortical electroencephalogram. J Neurosci 20:820-833.
30. Magill PJ, Bolam JP, Bevan MD (2000b) Neuronal activity in the globus pallidus during cortical inactivation in normal and 6-OHDA treated rats in vivo. Soc Neurosci Abstr 26:961.
31. Magill PJ, Bolam JP, Bevan MD (2001) Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience 106:313-330.
32. Meibach RC, Katzman R (1979) Catecholaminergic innervation of the subthalamic nucleus: evidence for a rostral condition of the A9 (substantia nigra) dopaminergic cell group. Brain Res 173:364-368.
33. Miller WC, DeLong MR (1987) Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In: The basal ganglia II (Carpenter MB, Jayaraman A, eds), pp 415-427. New York: Plenum.
34. Mink JW, Thach WT (1991) Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement. J Neurophysiol 65:330-351.
35. Ni Z, Bouali-Benazzouz R, Gao D, Benabid AL, Benazzouz A (2000) Changes in the firing pattern of globus pallidus neurons after the degeneration of nigrostriatal pathway are mediated by the subthalamic nucleus in the rat. Eur J Neurosci 12:4338-4344.
36. Olson RJ, Justice Jr JB (1993) Quantitative microdialysis under transient conditions. Anal Chem 65:1017-1022.
37. Orieux G, Francois C, Feger J, Yelnik J, Vila M, Ruberg M, Agid Y, Hirsch EC (2000) Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease. Neuroscience 97:79-88.
38. Pedneault S, Soghomonian JJ (1994) Glutamate decarboxylase (GAD65) mRNA levels in the striatum and pallidum of MPTP-treated monkeys. Brain Res Mol Brain Res 25:351-354.
39. Plenz D, Kitai S (1999) A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 400:677-682.
40. Raz A, Vaadia E, Bergman H (2000) Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 20:8559-8571.
41. Robertson RG, Graham WC, Sambrook MA, Crossman AR (1991) Further investigations into the pathophysiology of MPTP-induced parkinsonism in the primate: an intracerebral microdialysis study of gamma-aminobutyric acid in the lateral segment of the globus pallidus. Brain Res 563:278-280.
42. Salin P, Manrique C, Forni C, Kerkerian-Le Goff L (2002) High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. J Neurosci 22:5137-5148.
43. Schneider JS, Wade TV (2003) Experimental parkinsonism is associated with increased pallidal GAD gene expression and is reversed by site-directed antisense gene therapy. Mov Disord 18:32-40.
44. Schroeder JA, Schneider JS (2001) Alterations in expression of messenger RNAs encoding two isoforms ofglutamic acid decarboxylase in the globus pallidus and entopeduncular nucleus in animals symptomatic for and recovered from experimental Parkinsonism. Brain Res 888:180-183.
45. Sellal F, Hirsch E, Lisovoski F, Mutschler V, Collard M, Marescaux C (1992) Contralateral disappearance of parkinsonian signs after subthalamic hematoma. Neurology 42:255-256.
46. Shink E, Bevan MD, Bolam JP, Smith Y (1996) The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience 73:335-357.
47. Smith Y, Kieval JZ (2000) Anatomy of the dopamine system in the basal ganglia. Trends Neurosci 23:S28-S33.
48. Soghomonian JJ, Chesselet MF (1992) Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms ofglutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse 11:124-133.
49. Soghomonian JJ, Laprade N (1997) Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurons in the putamen of Parkinsonian monkeys. Synapse 27:122-132.
50. Soghomonian JJ, Pedneault S, Audet G, Parent A (1994) Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates. J Neurosci 14:6256-6265.
51. Vila M, Levy R, Herrero MT, Ruberg M, Faucheux B, Obeso JA, Agid Y, Hirsch EC (1997) Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci 17:765-773.
52. Wichmann T, DeLong MR (2003a) Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder. Ann NY Acad Sci 991:199-213.
53. Wichmann T, DeLong MR (2003b) Functional neuroanatomy of the basal ganglia in Parkinson's disease. Adv Neurol 91:9-18.
54. Wichmann T, Bergman H, Starr PA, Subramanian T, Watts RL, DeLong MR (1999) Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp Brain Res 125:397-409.
55. Wichmann T, Kliem MA, DeLong MR (2001a) Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates. Exp Neurol 167:410-424.
56. Wichmann T, Kliem MA, Soares J (2001b) Correlation between neuronal discharge in the basal ganglia and EEG in normal and parkinsonian primates. Soc Neurosci Abstr 27:749.23.
57. Winters WD, Kado RT, Adey WR (1969) A stereotaxic brain atlas for Macaca nemestrina. Berkeley, CA: Berkeley California Press.
58. Zhu Z, Bartol M, Shen K, Johnson SW (2002) Excitatory effects of dopamine on subthalamic nucleus neurons: in vitro study of rats pretreated with 6-hydroxydopamine and levodopa. Brain Res 945:31-40.